Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1986 1
1990 2
1991 2
1992 2
1993 1
1994 11
1995 3
1996 7
1997 11
1998 7
1999 5
2000 5
2001 8
2002 10
2003 14
2004 7
2005 8
2006 8
2007 6
2008 10
2009 14
2010 20
2011 14
2012 15
2013 11
2014 9
2015 19
2016 14
2017 15
2018 12
2019 16
2020 21
2021 24
2022 12
2023 12
2024 9
2025 12
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Results by year

Citations

6 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Autoimmune polyglandular syndrome type 4: experience from a single reference center.
Gatta E, Anelli V, Cimino E, Di Lodovico E, Piovani E, Zammarchi I, Gozzoli G, Maltese V, Cavadini M, Agosti B, Delbarba A, Pirola I, Girelli A, Buoso C, Bambini F, Alfieri D, Bremi W, Facondo P, Lupo R, Bezzi F, Fredi M, Mazzola AM, Gandossi E, Saullo M, Marini F, Licini M, Pezzaioli LC, Pini L, Franceschini F, Ricci C, Cappelli C. Gatta E, et al. Front Endocrinol (Lausanne). 2023 Oct 23;14:1236878. doi: 10.3389/fendo.2023.1236878. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37937054 Free PMC article.
PURPOSE: To characterize patients with APS type 4 among those affected by APS diagnosed and monitored at our local Reference Center for Autoimmune Polyglandular Syndromes. ...Type I diabetes mellitus was the leading indicator of APS type
PURPOSE: To characterize patients with APS type 4 among those affected by APS diagnosed and monitored at our local Reference C …
Autoimmune Polyglandular Syndrome type 2.
Martins SC, Venade G, Teixeira M, Olivério J, Machado J, Marques J, Matos LC. Martins SC, et al. Rev Assoc Med Bras (1992). 2019 Dec;65(12):1434-1437. doi: 10.1590/1806-9282.65.12.1434. Rev Assoc Med Bras (1992). 2019. PMID: 31994621 Free article.
Autoimmune polyglandular syndrome type 2 (APS 2) is defined by the presence of Addison's disease (AD) associated with autoimmune thyroid disease and/or Type 1 diabetes mellitus (T1DM). ...She had no leukocytosis, anemia, hypoglycemia, hyp
Autoimmune polyglandular syndrome type 2 (APS 2) is defined by the presence of Addison's disease (AD) associated
Polyglandular autoimmune syndrome type II.
Kahaly GJ. Kahaly GJ. Presse Med. 2012 Dec;41(12 P 2):e663-70. doi: 10.1016/j.lpm.2012.09.011. Epub 2012 Nov 16. Presse Med. 2012. PMID: 23159534 Review.
The polyglandular autoimmune syndromes (PAS) comprise a wide spectrum of autoimmune disorders. ...For PAS II, susceptibility genes are known which increase the risk for developing autoimmune disorders, but must not be causative. These are certain HLA g …
The polyglandular autoimmune syndromes (PAS) comprise a wide spectrum of autoimmune disorders. ...For PAS II, susceptib …
Autoinmune polyendocrinopathy.
Fernández Miró M, Colom Comí C, Godoy Lorenzo R. Fernández Miró M, et al. Med Clin (Barc). 2021 Sep 10;157(5):241-246. doi: 10.1016/j.medcli.2021.02.004. Epub 2021 May 3. Med Clin (Barc). 2021. PMID: 33958142 Review. English, Spanish.
Pluriglandular autoimmune syndrome (APS) can affect multiple endocrine glands and is associated with other autoimmune diseases. ...SPA type 2 presents with Addison's disease, type 1 diabetes, or autoimmune thyroid disease. ...
Pluriglandular autoimmune syndrome (APS) can affect multiple endocrine glands and is associated with other autoimmune d …
Atypical Forms of Diabetes.
Feingold KR. Feingold KR. 2025 Mar 10. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2025 Mar 10. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905351 Free Books & Documents. Review.
While most patients with diabetes have Type 1 diabetes (T1D) or Type 2 diabetes (T2D) there are other etiologies of diabetes that occur less frequently. ...In this chapter the following disorders that are associated with diabetes are discussed: 1) genetic disorders …
While most patients with diabetes have Type 1 diabetes (T1D) or Type 2 diabetes (T2D) there are other etiologies of diabetes t …
Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.
Betterle C, Furmaniak J, Sabbadin C, Scaroni C, Presotto F. Betterle C, et al. J Endocrinol Invest. 2023 Apr;46(4):643-665. doi: 10.1007/s40618-022-01994-1. Epub 2023 Jan 7. J Endocrinol Invest. 2023. PMID: 36609775 Review.
BACKGROUND: The number of recognised distinct autoimmune diseases (AIDs) has progressively increased over the years with more than 100 being reported today. ...These combinations are collectively termed type 3 Autoimmune Polyglandular Syndrome ( …
BACKGROUND: The number of recognised distinct autoimmune diseases (AIDs) has progressively increased over the years with more than 10 …
Autoimmune Polyendocrinopathy.
Frommer L, Kahaly GJ. Frommer L, et al. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4769-4782. doi: 10.1210/jc.2019-00602. J Clin Endocrinol Metab. 2019. PMID: 31127843
The prevalence is 1:100,000 and 1:20,000 for types I and types II to IV, respectively. Whereas type I (ORPHA 3453) is a monogenetic syndrome with an autosomal recessive transmission related to mutations in the autoimmune regulator (AIRE) gene, types II to IV …
The prevalence is 1:100,000 and 1:20,000 for types I and types II to IV, respectively. Whereas type I (ORPHA 3453) is a monogenetic …
Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge.
Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, Grymowicz M, Smolarczyk K, Kostrzak A, Smolarczyk R, Rudnicka E, Meczekalski B. Szeliga A, et al. Int J Mol Sci. 2021 Mar 5;22(5):2594. doi: 10.3390/ijms22052594. Int J Mol Sci. 2021. PMID: 33807517 Free PMC article. Review.
Most causes of POI remain undefined, however, it is estimated that anywhere from 4-30% of cases are autoimmune in origin. As the ovaries are a common target for autoimmune attacks, an autoimmune etiology of POI should always be considered, especially i …
Most causes of POI remain undefined, however, it is estimated that anywhere from 4-30% of cases are autoimmune in origin. As t …
Genetics of the autoimmune polyglandular syndrome type 3 variant.
Dittmar M, Kahaly GJ. Dittmar M, et al. Thyroid. 2010 Jul;20(7):737-43. doi: 10.1089/thy.2010.1639. Thyroid. 2010. PMID: 20578896 Review.
BACKGROUND: Autoimmune thyroid diseases (AITD) and type 1 diabetes (T1D) are the most common autoimmune endocrine disorders. ...This disease combination is denominated as autoimmune polyglandular syndrome type 3 variant (APS3v). Th …
BACKGROUND: Autoimmune thyroid diseases (AITD) and type 1 diabetes (T1D) are the most common autoimmune endocrine disor …
Autoimmune polyglandular syndrome type II with co-manifestation of Addison's and Graves' disease in a 15-year-old boy: case report and literature review.
Schulz L, Hammer E. Schulz L, et al. J Pediatr Endocrinol Metab. 2020 Apr 28;33(4):575-578. doi: 10.1515/jpem-2019-0506. J Pediatr Endocrinol Metab. 2020. PMID: 32112702 Review.
Background Autoimmune polyglandular syndrome type II (APS II) is defined as the combination of autoimmune adrenal insufficiency and autoimmune thyroid disease (AITD) and/or type I diabetes mellitus (T1DM) in the same patient. ...
Background Autoimmune polyglandular syndrome type II (APS II) is defined as the combination of autoimmune
353 results